
A new study reveals that heart attack survivors could greatly reduce their risk of a second event by starting combination cholesterol-lowering therapy sooner rather than later. By adding ezetimibe to statins within 12 weeks, patients lowered their bad cholesterol faster and significantly improved their odds of avoiding future heart attacks, strokes, or death. Despite this, [...]